Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study I

NCT03341689 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03341689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03341689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study I
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Completed
Start date
November 1, 2017
Completion date
October 31, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache